Tokyo, Aug. 2 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000058596) titled 'Additional testing for [Evaluation of the Effects of a 4-Week Consumption of Oligosaccharides on Bowel Movement Improvement (A)]' on Aug. 1.
Study Type:
Others,meta-analysis etc
Primary Sponsor:
Institute - Meiji Co., Ltd.
Condition:
Condition - N/A (Healthy adults)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To investigate the effect of yogurt intake on bile acids, immune markers, intestinal barrier function and fecal metabolites, and whether there is a relationship with bowel movements, intestinal flora, blood parameters, etc.
Basic objectives2 - Efficacy
Eligibility:
Age-lower limit - 20
years-old
Gender - Male and Female
Key inclusion criteria - The Per Protocol Set examined in the other study (UMIN000055373)
Key exclusion criteria - Subjects who declined to provide samples and information for this study during the information disclosure period
Target Size - 49
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2025 Year 07 Month 16 Day
Date of IRB - 2025 Year 07 Month 16 Day
Anticipated trial start date - 2025 Year 08 Month 01 Day
Last follow-up date - 2027 Year 03 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000066903
Disclaimer: Curated by HT Syndication.
